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Abstract 
We report a new method for the detection of regional DNA methylation using base-
dependent affinity interaction (i.e., adsoption) of DNA with graphene. Due to the strongest 
adsorption affinity of guanine bases towards graphene, bisulfite-treated guanine-enriched 
methylated DNA leads to a larger amount of the adsorbed DNA on the graphene-modified 
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electrodes in comparison to the adenine-enriched unmethylated DNA. The level of the 
methylation is quantified by monitoring the differential pulse voltammetric current as a 
function of the adsorbed DNA. The assay is sensitive to distinguish methylated and 
unmethylated DNA sequences at single CpG resolution by differentiating changes in DNA 
methylation as low as 5%. Furthermore, this method has been used to detect methylation 
levels in a collection of DNA samples taken from oesophageal cancer tissues. 
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1. Introduction 
DNA methylation is a cell-type specific epigenetic marker, essential for controlling gene 
expression via transcriptional regulation, silencing of repetitive DNA and genomic imprinting 
(Jones and Takai, 2001; Wu and Zhang, 2010). Current advances in DNA methylation 
research have suggested that different types of cancers  appear to have distinct DNA 
methylation levels at selected regions (i.e., regional methylation), which are responsible for 
their various responses to treatment (Taleat et al., 2015; Zhang et al., 2015). For example, 
regional methylation plays a fundamental role in the initiation and progression of 
oesophageal squamous cell carcinoma (ESCC) by inactivating transcription and loss of gene 
function (Chang et al., 2002; Delpu et al., 2013; Wong et al., 2006; Wong et al., 2003). Also, 
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DNA methylation based biomarker has proven to be used alone or in combination with other 
diagnostic methods in cancer (Delpu et al., 2013). Thus, detection of methylation in targeted 
cancer specific genes could have diagnostic and prognostic implications in human cancers. 
Over the past several decades, a number of conventional molecular biology 
approaches, including-bisulfite sequencing, MS-PCR, mass spectrometry and fluorescence 
based methods have been extensively used to measure the level of DNA methylation in 
cancers (Herman et al., 1996; Cao and Zhang, 2012; Zhang et al., 2011; Plongthongkum et 
al., 2014; Taleat et al., 2015; Zhang et al., 2015). These approaches employed sequencing, 
mass spectrometric or fluorescence readouts to differentiate between methylated and 
unmethylated sequences. They are relatively robust but are limited by the costly instruments, 
DNA fragmentation, chimeric product generation, fluorescent labels and long analysis time. 
Furthermore, these methods are limited by the background fluorescence interference as well 
as to high labour and bioinformatics costs. 
In the recent years, much attention has been focused on developing inexpensive and 
faster detection strategies based on colorimetry, electrochemistry, Raman scattering readouts 
(Carrascosa et al., 2014; Kato et al., 2011; Kato et al., 2008; Koo et al., 2014b; Kurita et al., 
2012; Taleat et al., 2015; Wang et al., 2016; Wee et al., 2015a; Wee et al., 2015b; Zhang et 
al., 2015). While all these methods have many advantages, their sensor fabrication procedure 
and data deconvolution methods are rather complicated due to the involvement of complex 
surface functionalisation steps or coupling chemistry (Carrascosa et al., 2014; Kato et al., 
2011; Kato et al., 2008; Koo et al., 2014b; Kurita et al., 2012; Taleat et al., 2015; Wang et al., 
2016; Wee et al., 2015a; Wee et al., 2015b; Zhang et al., 2015). Therefore, a simple and 
inexpensive method that could simplify the detection method by avoiding the complicated 
chemistry underlying each step of the sensor fabrication represents an appealing alternative to 
alleviate some of these issues. 
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More recently, we have reported a simple method for quantifying DNA methylation 
using different adsorption affinity of DNA bases onto an unmodified gold substrate (Koo et 
al., 2014a; Sina et al., 2014). Similar to gold substrate, graphene (Varghese et al., 2009) and 
graphene oxide (Wu et al., 2011) have been reported as promising substrates for adsorbing 
nucleobases and nucleosides. Over the past few years, several fundamental studies have been 
carried out to explore the nature of the direct interaction (i.e., adsorption) of nucleobases and 
nucleosides onto the graphene and graphene oxide surface (Gowtham et al., 2007; Varghese 
et al., 2009; Wu et al., 2011).
 
These studies have suggested that the physisorption between 
individual nucleobases and the graphene (i.e., adsorption on graphene) is controlled by the 
polarisabilities of the individual nucleobases. Among all nucleobases, guanine and adenine 
with their five- and six-membered rings possess the largest polarisabilities, whereas other 
bases with only six-membered rings exhibit lower polarisabilities. Additionally, guanines 
with its double-bonded oxygen atom possess a larger polarisability than adenine. Since the 
van der Wall (vdW) energy is directly proportional to the interacting nucleobases, Scheicher 
(Gowtham et al., 2007) and Rao (Varghese et al., 2009) have proposed that vdW interaction 
is indeed the main driving force for the adsorption of  nucleobases onto the graphene and 
follows the adsorption trend as guanine (G)> adenine (A)> thymine (T)> cytosine (C). 
Because this interaction is base (i.e., sequence) dependent and bisulfite conversion generates 
two DNA sequences with different base compositions, bisulfite-converted two DNA 
sequences should give different adsorption patterns on graphene surface. To date, there is no 
other method that uses the graphene-DNA affinity interaction to quantify DNA methylation. 
Herein, we report a simple and inexpensive method for detecting regional DNA 
methylation using direct adsorption of bisulfite-treated and PCR amplified DNA sequences 
onto graphene-modified screen-printed carbon electrode (g-SPCE). In this approach, 
following the bisulfite conversion and asymmetric PCR amplifications steps, the amplified 
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products was directly adsorbed on g-SPCE. The relative adsorption of the amplified products 
was then detected via differential pulse voltammetry (DPV) in the presence of the [Fe(CN)6]
3-
/4-
 redox system. We first optimized the adsorption parameters (i.e., adsorption time, pH of 
the solution, etc) to achieve optimal analytical performance of the method. Then, we applied 
this method to detect FAM134B promoter gene methylation in a panel of ESCC cell lines and 
patient samples derived from oesophageal squamous cell carcinoma. Finally, we established a 
correlation between promoter hypermethylation and FAM134B gene expression levels.  
 
2. Experimental 
2.1 Materials 
 
All reagents were of analytical grade and purchased from Sigma Aldrich (St Louis, MO, 
USA). UltraPureTM DNase/RNase-free distilled water (Invitrogen, Carlsbad, CA, USA) was 
used throughout the experiments. Jurkat 100% methylated genomic DNA was purchased 
from New England Biolabs (Ipswich, MA, USA). Two oesophageal squamous cell carcinoma 
(ESCC) cell lines, HKESC-1 and HKESC-4, were kindly gifted from Department of 
Pathology, University of Hong Kong. Another ESCC cell line- KYSE-510 was purchased 
from Leibniz Institute DSMZ (German collection of microorganisms and cell cultures).  All 
these cell lines were grown in minimum essential medium alpha (MEMα growth medium, 
Gibco (ThermFisher scientific, Waltham, MA, USA) medium with non-essential amino acids 
supplemented with 10% fetal bovine serum (FBS, Gibco), 100 µg/mL penicillin (Gibco) and 
100 unit/mL streptomycin (Gibco) in a  humidified cell culture incubator containing 5% CO2  
at 37°C. Graphene-modified screen-printed carbon electrodes (g-SPCE, 110GPH) were 
acquired from Dropsens (Spain). 
 
6 
 
2.2 Clinical samples 
 
Surgically resected fresh tissue samples (cancer and matched non-cancer) from eight ESCC 
patients were used for this study. Histopathological confirmation of carcinoma was made 
prior to DNA isolation. All ESCC patients selected in this study were free from 
radio/chemotherapy and were matched with gender (all male) and clinical staging (stage III & 
IV). Mean age group of the patients were 65+ 14, ranging from 45-74 years. Ethical approval 
has been obtained for the use of these samples (GU Ref No: MED/19/08/HREC). The 
selected samples were sectioned using a cryostat (Leica CM 1850 UV, Wetzlar, Germany) 
and stained by haematoxylin and eosin. 
 
2.3 Genomic DNA extraction  
 
HKESC-1, HKESC-4 and KYSE-510 ESCC cell lines were grown in minimum essential 
medium alpha (MEMα growth medium, Gibco (ThermFisher scientific, Waltham, MA, USA) 
medium with non-essential amino acids supplemented with 10% fetal bovine serum (FBS, 
Gibco), 100 µg/mL penicillin (Gibco) and 100 unit/mL streptomycin (Gibco) in a  humidified 
cell culture incubator containing 5% CO2  at 37°C. Genomic DNA was extracted and purified 
from 10
5
 cell plates of the aforesaid cell lines and clinical samples using DNeasy blood and 
tissue kit (Qiagen Pty. Ltd., Venlo, Netherlands) following manufacturer’s instructions. 
Briefly, after harvesting, appropriate number of cells was suspended in phosphate buffer 
solutions. A digestion step was executed to remove the protein and RNA in the solution via 
proteinase and RNase enzymes, respectively. Then, cell samples were suspended in lysis 
buffer to disrupt and release the nucleic acids and proteins into the solution. The digested 
proteins and RNA were removed by centrifuging the solution in a spin column. The purified 
DNA was eluted from the column in 100 μL of elution buffer and stored at -20°C. The whole 
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genomic amplified (WGA) DNA samples was prepared through amplifying about 50 ng 
genomic DNA using REPLI-g whole genome amplification kit (Qiagen Pty. Ltd., Venlo, 
Netherlands) according to manufacturer’s instructions. DNA quantification was achieved via 
Nanodrop Spectrophotometer (BioLab, Ipswich, MA, USA) and purity was measured using 
260/280 ratio. Concentration of DNA was noted in ng/µL and then stored at -20˚C until use. 
 
2.4 Bisulphite treatment 
 
MethylEasy
TM
 Xceed kit (Human Genetic Signatures Pty. Ltd., NSW, Australia) was used to 
perform bisulphite conversion as per the manufacturer instruction. Briefly, 500 ng of DNA 
were incubated with 150 mM NaOH solution at 37 °C for 15 minutes followed by treatment 
with sodium bisulfite at 80 °C for 45 minutes. Then bisulfite-treated DNA solution was 
purified using the protocol from MethylEasy
TM
 Xceed kit. DNA quantification and purity 
was checked via Nanodrop Spectrophotometer (BioLab, Ipswich, MA, USA). Concentration 
of bisulphite treated DNA was noted in ng/µL and then stored at -20˚C until use. 
 
2.5 Normalization of DNA copy number 
 
In order to normalize the DNA copy number from each DNA source, the relative amount of 
FAM134B (JK1) genes in bisulphite treated cell and WGA DNA samples were determined by 
real-time amplification of the house keeping HBD gene using the Rotor-Gene Q detection 
system (Qiagen, Hilden, Germany) and performing comparative analysis of Ct (i.e. the 
fractional PCR cycle number at which the reporter fluorescence is greater than the threshold). 
qRT-PCR was performed in a total volume of 10 µL reaction mixture comprising 5 µL of 
2XSensiMix SYBR No-ROX master mix (Bioline, London, UK), 1 µL of each 250 nM 
primer, 1 µL of equal concentrated target cell and WGA DNA samples with 2 µL of 
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nuclease-free water. Thermal cycling programs encompassed initial denaturation and activate 
the hot start DNA polymerase in one cycle of 7 minutes at 95 °C followed by 40 cycles of 10 
seconds at 95°C (denaturation), 30 seconds at 60°C (annealing) and 20 seconds at 72°C 
(extension). 
 
2.6 Asymmetric PCR 
 
 Asymmetric PCR of the bisulphite treated DNA was carried out using AmpliTaq Gold 360 
master mix (ThermFisher scientific, Waltham, MA USA) to generate ss-DNA amplicons. 
Asymmetric PCR was performed by suing 60 µL reaction mixture comprising 30 µL of 
AmpliTaq Gold 360 master mix, 1 µL of 125 nM forward primer and 375 nm reverse primer 
(see Table S1), 1 µL of 50 ng bisulphite treated DNA and 28 µL of nuclease-free water. PCR 
cycling programs was performed under the following conditions: 95°C for 10 minutes 
followed by 49 cycles of 30 seconds at 95°C (denaturation), 30 seconds at 61°C (annealing) 
and 20 seconds at 72°C (extension). 
 
2.7 Methylation specific-high resolution melting (MS-HRM) curve analysis 
MS-HRM was performed according to the modified versions of the previously published 
procedure (Wojdacz and Dobrovic, 2007). Briefly, HRM curve analysis was carried out on 
the Rotor-Gene Q detection system (Qiagen) using the Rotor-Gene ScreenClust Software. 
PCR was performed in a 10 μL total volume containing 5 μL of 2Xsensimix HRM master 
mix, 1 μL of 20 ng/μL bisulfite modified genomic DNA, 2 μL RNase free water and 1 μL of 
each primer. The thermal profile comprised 15 min at 95°C, followed by 50 cycles of 30 
seconds at 95°C, 30 seconds at 61°C and 20 second at 72°C. High resolution melting 
analyses were carried out at temperature ramping from 70-95°C. The normalization of 
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melting curve were performed following the previous procedure (Wojdacz and Dobrovic, 
2007). 
 
2.8 Electrochemical measurements of DNA methylation 
 
All electrochemical measurements were performed on a CH1040C potentiostat (CH 
Instruments, Bee Cave, TX, USA) with the three-electrode system printed on a ceramic 
substrate (length 33 x width 10 x height 0.5) mm. In the three-electrode system, working 
(diameter = 4mm), counter and reference electrodes were graphene/carbon, carbon, and 
silver-modified electrodes. Differential pulse voltammetry experiments were conducted in 10 
mM phosphate buffered saline (PBS) solution containing 2.5mM [K3Fe(CN)6] and 2.5mM 
[K4Fe(CN)6] electrolyte solution. DPV signals were obtained with a potential step of 5 mV, 
pulse amplitude of 50 mV, pulse width of 50 ms, and pulse period of 100 ms. For synthetic 
DNA samples, 8 μL (diluted in SSC5X buffer to get 100 nM of DNA) sample was adsorbed 
on g-SPCE surface. For cell lines and clinical samples analysis, 10 times-diluted amplified 
products (i.e., 20 μL of amplified DNA spiked in 200 μL of SSC5X buffer) were used for 
adsorption experiments. The electrodes were then washed three times with PBS prior to 
perform DPV measurements. The relative DPV current changes (i.e., %IRelative, percent 
difference of the DPV signals generated for DNA sample (ISample) with respect to the baseline 
current (IBaseline)) due to the adsorption of DNA samples were then measured by using 
equation 1. The difference in relative DPV signals between unmethylated and methylated 
DNA was calculated by using equation 2. 
 
            
                   
          
      … … … … …        (1) 
IRelative = %IRelative, M - %IRelative, UM  … … … … … (2) 
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where %IRelative, M and %IRelative, UM are the relative DPV signals for the methylated, and 
unmethylated samples, respectively. 
 
 
2.9 Fourier Transform Infrared Spectroscopy and UV-Vis Experiments  
Fourier Transform Infrared Spectroscopy (FTIR) spectra were collected on a Perkin-
Elmer Spectrum 100 with a resolution of 4 cm
-1
 in absorption mode. A baseline correction 
was applied after the measurement. The measurements were performed for a bare graphene-
modified and DNA/graphene-modified working electrode. UV-vis absorption spectra were 
measured on Agilent 8453 UV-Vis spectrometer. The UV-vis measurements were done in 
aqueous solution. 
 
 
 
3 Results and discussion 
 
3.1 Principle 
 
Fig. 1 illustrates the principle of the method. Briefly, ds-DNAs were first extracted from the 
cancer cell lines. A bisulfite conversion step was then performed to convert unmethylated 
cytosines in ds-DNA (double stranded DNA) into uracils while methylated cytosines remain 
unchanged. In a subsequent asymmetric PCR amplification step, all ds-DNA were converted 
to ss-DNA (single stranded DNA) amplicons. In this step, cytosines in the complementary 
strand will be copied to guanines and uracils to adenines resulting in methylated sample into 
guanine-enriched and unmethylated into adenine-enriched ss-DNA. These samples were then 
directly adsorbed on the g-SPCE surface. The DNA-attached g-SPCE surfaces were 
characterised by FTIR analysis. The interaction between graphene and DNA sequences has 
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also been tested in solution phase via UV-Vis spectrometry (for details see text and Fig S1 in 
Supplementary Material). The adsorbed ss-DNA amplicons were detected by differential 
pulse voltammetry (DPV) in the presence of a small redox active [Fe(CN)6]
3-/4-
 group. 
Previously, we (Koo et al., 2014a; Sina et al., 2014) and Zhang et al. (Zhang et al., 2007) 
have shown that unlike conventional redox system (e.g., [Ru(NH3)6]
3+
/[Fe(CN)6]
3-
) (Das et 
al., 2012), the [Fe(CN)6]
3-/4-
 alone is sufficient for quantifying surface-bound sequences 
reliably. As outlined by Zhang et al. (Zhang et al. 2007), the process follows an electron 
transfer kinetics-based mechanism, where density of the adsorbed DNA sequences at the 
electrode surface should be sufficiently low (i.e., partial blocking). Under this condition, the 
columbic repulsion between the surface-bound ss-DNA and [Fe(CN)6]
3- 
is not strong enough 
to fully repel [Fe(CN)6]
3-
molecules from accessing the surface. Therefore, it generates a 
significant DPV signal which is lower than that of the un-modified electrode (i.e., before ss-
DNA adsorption) (Koo et al., 2014a; Sina et al., 2014). In the current method, since the 
adsorption strength of DNA bases towards graphene vary as G>A>T>C, the guanine-
enriched methylated DNA leads to a larger level of adsorbed DNA on the electrodes in 
comparison to the adenine-enriched unmethylated DNA. Hence, as schematically shown in 
Fig.1, methylated DNA results in a smaller DPV current (i.e., larger relative current change, 
%IRelative).   
 
We have first explored the oncogenic properties and altered expression of FAM134B 
(JK1) gene in oesophageal squamous cell carcinoma (Tang et al., 2007).
 
Also, FAM134B has 
been reported to have roles in pathogenesis as well as prediction of prognosis of other 
gastrointestinal cancer, namely colorectal cancer (Kasem et al., 2014). Most current 
approaches detect DNA methylation in oesophageal cancers via methylation specific PCR 
amplification process (Kuroki et al., 2003; Long et al., 2007). In this proof-of-concept study, 
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we have used graphene-DNA affinity interaction for detecting gene-specific DNA 
methylation in FAM134B. Firstly, the FAM134B promoter region containing 11 CpG sites 
located within a length of 60 bases was chosen as a target DNA. In order to further validate 
our approach, we have designed synthetic samples containing 0, 1, 5 and 11 CpG sites within 
the promoter region of FAM134B gene which mimic the bisulfite treated and asymmetric 
PCR processed methylated and unmethylated DNA regions (See Table S1, Supplementary 
Material). 
One of the key considerations of the current method is that there is only a finite 
amount of electrode area and we should have the right amount of adsorbed DNA on the 
electrode surface so that the extent of methylation makes discernible signal difference. 
Therefore, we first optimised adsorption time and pH of the solution to achieve optimal 
amount of adsorbed DNA on the electrode surface so that the affinities of the DNA with 
different amounts of methylation can be discerned. Relative current differences (IRelative, see 
Experimental) between the 100 nM methylated (11 CpG) and unmethylated (0 CpG) DNA 
samples were measured.  As seen in Fig. S2, an adsorption time of only 1 min is sufficient to 
generate a significant IRelative value. The maximum IRelative was found at 2 min, which was 
rapidly decreased with increasing adsorption time. Long adsorption time (>10 min) would 
lead to large amount of adsorbed DNA (i.e., complete block of the surface) on electrode 
surface. This results in a similar level of columbic repulsion between the surface-bound DNA 
and [Fe(CN)6]
3- 
for both the methylated and unmethylated cases, providing two DPV signals 
with almost identical magnitudes leading to a small IRelative changes. 
We then evaluated the pH-dependent IRelative changes by varying the pH of the 
solution from 3.0 to 9.5 (Fig. S3). Clearly, both methylated and unmethylated DNA samples 
could be distinguished at all the pH examined. The optimal IRelative value was found at pH 
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7.4. This can be explained by the fact that negative charge of the phosphate backbone of 
DNA at this pH is optimal to hinder the graphene-DNA interaction for both methylated and 
unmethylated samples while still allowing the methylated DNA with higher guanine contents 
to be interacted strongly. At the lower pH, the N3 position of the cytosines in methylated and 
unmethylated sequences can be protonated (pKa = 4.2) (Wu et al., 2011). This may contribute 
to reduce the Van-der Wall interaction (i.e., electrostatic repulsion) between targets 
sequences and graphene surface, and thus result in a lower adsorption, leading to higher DPV 
currents (i.e., lower IRelative changes). At the higher pH, the electrostatic interaction 
(adsorption) between graphene and DNA sequences is very strong, which significantly 
contribute to facilitate their adsorption on graphene-modified surfaces (i.e., both targets reach 
to the saturation level within a very short time giving a reduced IRelative value). 
The main advantage of gold standard sequencing-bisulfite based method is that they 
can detect DNA methylation with single-base resolution. To evaluate the feasibility of our 
assay for detecting a minimum number of CpG methylation, four synthetic DNA samples 
containing 0, 1, 5 and 11 CpG sites were tested (as outlined above and in Table S1, 
Supplementary Material). Fig. 2 shows that the decrease of the relative current changes is a 
function of the number of CpG cites. This is due to the increase of the guanine contents with 
increasing methylated CpG sites in the target sequence. The level of relative adsorption 
pattern of methylated CpG sites agreeably implies the high specificity of our assay for 
effective detection of DNA methylation at a single CpG level of resolution.  
Since tissue samples from patients with cancer usually contain a mixture of 
methylated and unmethylated DNA, accurate quantification of heterogeneous DNA 
methylation pattern is significant for detection and prediction of various clinicopathological 
parameters in cancers. It is therefore important to detect the degree of methylation in a high 
background of unmethylated DNA samples. To evaluate the assay performance for detecting 
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heterogeneous DNA methylation pattern, we analysed the dependence of the relative current 
changes on various degree of methylation. The samples were prepared by mixing synthetic 
standards of methylated and unmethylated DNA sequences to get 0%, 5%, 25%, 50%, 75%, 
95% and 100% methylation, Fig. 3. The relative current changes (%IRelative) increases with 
increasing levels of methylation, probably due to the increasing guanine contents in the target 
DNA sequences (i.e., low DPV current and thus the higher %IRelative).  The linear regression 
equation was y (%IRelative) = 2.3193x + 20.77(C) with a correlation coefficient (r
2
) of 0.9921. 
A methylation change as low as 5% could be detected from 100 nM of DNA. These data was 
much better than our previous gold-DNA based approach (Koo et al. 2014a; Sina et al. 2014) 
and was of comparable to recent approaches (Carrascosa et al., 2014; Koo et al., 2014b; 
Wang et al., 2016; Wee et al., 2015a; Wee et al., 2015b),
 
and clearly demonstrate that our 
approach is both specific and sensitive in detecting methylated DNA in the nanogram regime. 
To test the applicability of our assay for detecting methylation level of FAM134B 
promoter gene, DNA samples derived from three ESSC cell lines were tested, Fig. 4A. A 
fully unmethylated whole genome amplified DNA was used as an internal standard. For 
avoiding any PCR bias, as outlined in our previously reported methylsorb assay (Koo et al., 
2014a; Sina et al., 2014), we normalized the gene copy number prior to PCR amplification 
(see Experimental for details). As expected, for all the three cancer cell lines and WGA 
samples, significant relative current changes were observed indicating the presence of 
different degree of methylation. Importantly, two of the cell-derived samples (i.e., KYSE-510 
and HKESC-1) resulted in a large relative current changes when compared to that of the 
unmethylated WGA (e.g., IRelative between KYSE-510 cell lines and unmethylated WGA 
was found to be ~14.6%), indicating DNA sequence derived from KYSE-510 and HKESC-1 
cell lines could be hypermethylated at FAM134B promoter gene. These data clearly indicate 
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that the proposed assay may be a useful alternative for detecting FAM134B promoter gene 
methylation in cell-derived samples. 
To further demonstrate the applicability of our method in analysing clinical samples, 
we extended our assay to analyse six tissue DNA samples derived from patients with primary 
oesophageal squamous cell carcinoma. Two oesophageal non-cancerous tissue DNA samples 
were also used as a control (see Experimental for details). Fig. 4B indicates that all samples 
showed different degree of methylation. The level of relative current changes with respect to 
that of the WGA obtained for two normal samples clearly show that these two samples are 
unmethylated. Also by comparing the level of relative current changes found in cell lines 
(Fig. 4A), we can estimate that four DNA samples derived from P3, P4, P5 and P6 cancer 
patients were highly methylated, while P1 and P2 samples were partially methylated (i.e., low 
methylation) at FAM134B promoter gene. We then validated our assay performance with 
well-known MS-HRM curve analysis. As can be seen in Fig S5, WGA and N1 samples have 
almost similar methylation level. Also the P6 sample has relatively higher methylation level 
compare to that of the P2 sample. These data are in-line with our adsorption based data.   
Previously, it has been reported that gene silencing due to promoter hypermethylation 
play a fundamental role in pathogenesis of oesophageal squamous cell carcinoma (Wong et 
al. 2006). To evaluate whether the promoter hypermethylation of the FAM134B gene is 
linked with oesophageal cancer development, the FAM134B mRNA expression in all studied 
samples were examined via qRT-PCR (see Fig. S4 and experimental details in 
Supplementary Material). While our assay have showed higher level of methylation (i.e., 
aberrant promoter hypermethylation) of the FAM134B gene in four primary cancer patients 
(P3, P4, P5 and P6 in Fig 4B), the mRNA expression study revealed under-expression in 
three of these DNA samples (P4, P5 and P6, Fig S4 in Supplementary Material). 
Furthermore, mRNA over-expression was found in three patient samples (P1, P2, P3), 
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indicating that the associated CpG region could be unmethylated or partially methylated.  In 
our assay, we have noted that the levels of methylation for P1 and P2 samples are slightly 
higher than those of WGA (see Fig. 4A) and normal samples (N1 and N2 in Fig. 4B), 
indicating that these two samples (P1 and P2) could be partially methylated, and is in good 
agreement with RNA-expression data. In contrast, P3 sample showed significantly higher 
methylation levels than normal and WGA samples. This outcome suggests that this region 
could be hypermethylated, in disagreement with our mRNA expression data. The 
electrochemical data presented here clearly suggests that there is a relationship between 
promoter methylation level and mRNA expression of FAM134B gene in oesophageal 
squamous cell carcinoma, and support the accuracy of our assay. Although an in-depth study 
is needed to fully evaluate and validate clinical utility of the method, the analytical 
performance of the assay in its current form suggests the high feasibility of our assay in 
clinical sample analysis. 
4 Conclusion 
We have developed a simple and new method for the quantification of gene-associated 
DNA methylation using affinity interaction between DNA bases and graphene. The method is 
based on the different adsorption affinity of DNA nucleotides towards graphene-modified 
electrodes. The detection was achieved by the direct adsorption of two sequentially different 
DNA samples (bisulfite-treated and PCR amplified sequences representing methylated and 
unmethylated DNA) onto a graphene-modified electrode, which avoids multiple 
modifications and functionalisation steps involved in conventional assays. Furthermore, it 
avoids the need for sequencing analysis. Most importantly, we have tested the feasibility of 
our assay to detect methylation target of FAM134B promoter gene in a panel of ESCC cell 
lines and clinical samples from ESCC patients. We anticipated that our assay might be able to 
detect global hypomethylation since the methylated and unmethylated DNA-base changes of 
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bisulfite treated genomes entails a large number of CpG sites, which might generate a marked 
adsorption difference between fully methylated and partially methylated samples. In addition, 
our assay could be viably useful in clinical diagnostics because of its potential for accurate 
detection of epigenetic biomarker. 
 
Acknowledgement 
This work was supported by the NHMRC CDF (APP1088966 to M.J.A.S.), Griffith 
University New Researcher Grant Scheme and higher degree research scholarships (GUIPRS 
and GUPRS scholarships to M.H.H. and M.N.I.) from the Griffith University. 
 
Appendix A. Supplementary Material 
Supplementary data associated with this article can be found in the online version at http:// 
 
References 
Cao, A., Zhang, C.Y. 2012. Anal Chem.84, 6199-6205. 
Carrascosa, L.G., Sina, A.A., Palanisamy, R., Sepulveda, B., Otte, M.A., Rauf, S., Shiddiky, 
M.J., Trau, M., 2014. Chem. Commun. 50, 3585-3588. 
Chang, H.W., Chow, V., Lam, K.Y., Wei, W.I., Yuen, A., 2002. Cancer. 94:386-92.  
Das, J., Cederquist, K.B., Zaragoza, A.A., Lee, P.E., Sargent, E.H., Kelley, S.O., 2012. Nat. 
Chem. 4, 642-648. 
Delpu, Y., Cordelier, P., Cho, W.C., Torrisani, J., 2013. Int. J. Mol. Sci. 14, 15029-15058. 
Gowtham, S., Scheicher, R.H., Ahuja, R., Pandey, R., Karna, S.P., 2007. Phys. Rev. B. 76, 
article number 033401. 
Herman, J.G., Graff, J.R., Myöhänen, S., Nelkin, B.D., Baylin, S.B. 1996. Proc. Natl. Acad. 
Sci. U. S. A. 93, 9821-9826.  
Jones, P.A., Takai, D., 2001. Science. 293, 1068-1070. 
Kasem, K., Gopalan, V., Salajegheh, A., Lu, C.T., Smith, R.A., Lam, A.K.Y., 2014. Exp Cell 
Res. 326, 166-173. 
18 
 
Kato, D., Goto, K., Fujii, S.-i., Takatsu, A., Hirono, S., Niwa, O., 2011. Anal. Chem. 83, 
7595-7599. 
Kato, D., Sekioka, N., Ueda, A., Kurita, R., Hirono, S., Suzuki, K., Niwa, O., 2008. J. Am. 
Chem. Soc. 130, 3716-3717. 
Koo, K.M., Sina, A.A., Carrascosa, L.G., Shiddiky, M.J., Trau, M., 2014a. Analyst. 139, 
6178-6184. 
Koo, K.M., Wee, E.J., Rauf, S., Shiddiky, M.J., Trau, M., 2014b. Biosens. Bioelectron. 56, 
278-285. 
Kurita, R., Arai, K., Nakamoto, K., Kato, D., Niwa, O., 2012. Anal. Chem. 84, 1799-1803. 
Kuroki, T., Trapasso, F., Yendamuri, S., Matsuyama, A., Alder, H., Mori, M., Croce, C.M., 
2003. Clin. Cancer Res. 9, 1441-1445. 
Long, C., Yin, B., Lu, Q., Zhou, X., Hu, J., Yang, Y., Yu, F., Yuan, Y., 2007. Cancer Invest. 
25, 685-690. 
Plongthongkum, N., Diep, D.H., Zhang, K., 2014. Nat. Rev. Genet. 15, 647-661. 
Sina, A.A., Howell, S., Carrascosa, L.G., Rauf, S., Shiddiky, M.J., Trau, M., 2014. Chem. 
Commun. 50, 13153-13156. 
Taleat, Z., Mathwig, K., Sudhölter, E.J.R., Rassaei, L., 2015. Trac- Trends Anal. Chem. 66, 
80-89. 
Tang, W.K., Chui, C.H., Fatima, S., Kok, S.H., Pak, K.C., Ou, T.M., Hui, K.S., Wong, M.M., 
Wong, J., Law, S., Tsao, S.W., Lam, K.Y., Beh, P.S., Srivastava, G., Chan, A.S., Ho, K.P., 
Tang, J.C., 2007. Int. J. Mol. Med. 19, 915-923. 
Varghese, N., Mogera, U., Govindaraj, A., Das, A., Maiti, P.K., Sood, A.K., Rao, C.N.R., 
2009. ChemPhysChem. 10, 206-210. 
Wang, Y., Wee, E.J.H., Trau, M., 2016. Chem. Commun. 52, 3560-3563. 
Wee, E.J., Rauf, S., Shiddiky, M.J., Dobrovic, A., Trau, M., 2015a. Clin. Chem. 61, 163-171. 
Wee, E.J.H., Ha Ngo, T., Trau, M., 2015b. Sci. Rep. 5, article number15028. 
Wojdacz, T.K., Dobrovic, A., 2007. Nucleic Acids Res. 35, e41. 
Wong, M.L., Tao, Q., Fu, L., Wong, K.Y., Qiu, G.H., Law, F.B., Tin, P.C., Cheung, W.L., 
Lee, P.Y., Tang, J.C., Tsao, G.S., Lam, K.Y., Law, S., Wong, J., Srivastava, G., 2006. Int. 
J. Oncol. 28, 767-773. 
Wong, T.S., Man, M.W., Lam, A.K., Wei, W.I., Kwong, Y.L., Yuen, A.P., 2003. Eur. J. 
Cancer. 39, 1881-1887. 
Wu, M., Kempaiah, R., Huang, P.-J.J., Maheshwari, V., Liu, J., 2011. Langmuir. 27, 2731-
2738. 
19 
 
Wu, S.C., Zhang, Y., 2010. Nat. Rev. Mol. Cell. Biol. 11, 607-620. 
Zhang, J., Wang, L., Pan, D., Song, S., Fan, C., 2007. DNA hybridization "turns on" 
electrocatalysis at gold electrodes. Chem. Commun. 11, 1154-1156. 
Zhang, J.J., Zhang, L., Zhou, K., Ye, X., Liu, C., Zhang, L., Kang, J., Cai, C. 2011. Anal 
Biochem. 413,164-170.  
Zhang, L., Xu, Y.-Z., Xiao, X.-F., Chen, J., Zhou, X.-Q., Zhu, W.-Y., Dai, Z., Zou, X.-Y., 
2015. Trac- Trends Anal. Chem. 72, 114-122. 
 
 
 
 
 
Figure Captions 
Fig. 1. Schematic of graphene-DNA adsorption based methylation assay. The adsorption of 
ss-DNA on g-SPCE repulse [Fe(CN)6]
3-
 molecules from accessing electrode surface, 
providing a significate DPV signal. Inset, typical differential pulse voltammetric signals 
showing the guanine-enriched methylated DNA that produces lower DPV currents in 
comparison to the adenine-enriched unmethylated DNA. 
Fig. 2. Left, Differential pulse voltammetric current changes with respect to the designated 
CpG sites. Right, typical DPV signal for the sample containing 1 CpG site and its 
corresponding background signal. Each data point represents the average of three repeat 
trails, and error bars represent the standard deviation of measurements (%RSD = <5% for n = 
3).   
Fig. 3. Differential pulse voltammetric current changes with respect to the designated 
methylation level. Inset, typical DPV signals for the sample containing 5% (left, top) and 
95% (right, bottom) and their corresponding background signals. Each data point represents 
the average of three repeat trails, and error bars represent the standard deviation of 
measurements (%RSD = <5% for n = 3). 
Fig. 4. Relative current changes for detecting FAM134B promoter region in (A) three 
oesophageal cancer cell lines and unmethylated, and (B) two normal (N1 and N2) and six 
(P1-P6) oesophageal cancer tissue samples. Each data point represents the average of three 
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repeat trails, and error bars represent the standard deviation of measurements (%RSD = <5% 
for n = 3). 
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